CASTELEIN CALEY received a stock award from WHITEHAWK THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/18/2026ACC: 0001355758-26-000003
Director
Since Sep 2018
+2.33M
Net shares
Net buyer
$1000.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.33M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+255.10K
Price / share
$3.92
Trade value
$1000K
% of position
1295.3%
5/14/2026
19.69K→274.80K
Total
Net shares
+255.10K
Net value
$1000K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | A · Award | +255.10K | $3.92 | $1000K | 1295.3% | 19.69K | 274.80K |
| Total | +255.10K | $1000K | ||||||
Derivative Transactions1
Pre-Funded Warrant (right to buy)
Indirect
Converts to
Common Stock
2.07M shares
Shares
+2.07M
Strike price
.0001
Held after
2.07M
Exercisable
—
5/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-Funded Warrant (right to buy) Indirect | Common Stock2.07M shares | 5/14/2026 | A · Award | +2.07M | .0001 | — | 2.07M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.17M
Total
2.17M indirect2.17M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.17M | Indirect |
| Total | 2.17M | 2.17M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported